Term ends Apr 29, 2029 · High confidence
20-year base term ends Apr 29, 2029
Held by Enzo Therapeutics, Inc.
Filed Aug 31, 2009 as application 12/584,131 · Granted Nov 20, 2012
Base term, 20 years from filing
Today
2009
2029
Clock starts
Apr 29, 2009
Apr 29, 2009
Term ends
Apr 29, 2029
Apr 29, 2029
Granted
Nov 20, 2012
Nov 20, 2012
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,314,151, US 8,372,888, to Apr 29, 2029. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 29, 2009, when application 12/387,228, the earliest non-provisional in its chain, was filed (this one was filed Aug 31, 2009) | Apr 29, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,314,151, US 8,372,888) | resolves to Apr 29, 2029, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 29, 2029 | High confidence |
This family
| US 8,372,888 | In force Apr 2029 | Apr 2029 |
| US 8,314,151 | this patent Apr 2029 | Apr 2029 |
| Application PCT/US2010/032939 | PCT application no patent term | no patent term |
| US 9,388,121 | In force Apr 2029 | Apr 2029 |
| US 9,974,758 | In force Apr 2029 | Apr 2029 |
| US 10,166,204 | In force no later than Apr 2029 | no later than Apr 2029 |
| US 10,456,370 | In force no later than Apr 2029 | no later than Apr 2029 |
| US 10,624,863 | In force no later than Apr 2029 | no later than Apr 2029 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 2, 2011 Reel 26856, frame 405 | Zipkin, Robert Elliot; Adams, Jeffrey Kroll | Enzo Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 2, 2011 Reel 26856, frame 436 | Spiegel, Sarah | Virginia Commonwealth University | Assignment of Assignor's Interest |
| Mar 19, 2012 Reel 27891, frame 744 | Zipkin, Robert Elliot; Adams, Jeffrey Kroll; Spiegel, Sarah | Enzo Therapeutics, Inc. C/O Enzo Biochem, Inc. | Assignment of Assignor's Interest |
| Oct 2, 2014 Reel 33918, frame 338 | Spiegel, Sarah | Virginia Commonwealth University | Assignment of Assignor's Interest |
| Oct 2, 2014 Reel 33940, frame 642 | Zipkin, Robert Elliot; Adams, Jeffrey Kroll | Enzo Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2029
Term ends Apr 29, 2029. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,314,151, US 8,372,888, ends no earlier than this term, so it caps nothing.
Citations
19
later US patents cite this one
That is above the median of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.